Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Filings indexed 2,308 across all filing types
Latest filing 2008-10-31 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2008
Regulatory Filings
2008-10-31 Danish
Board/Management Information 2008
Board/Management Information Classification · 99% confidence The document is a short announcement titled "ÆNDRING I NOVOZYMES' BESTYRELSE" (Change in Novozymes' Board of Directors). It explicitly states that a board member, Hans Werdelin, is resigning effective October 31, 2008. This content directly relates to changes in the company's board of directors or senior management. This matches the definition for Board/Management Information (MANG). The document length is very short (1131 chars), confirming it is an announcement rather than a comprehensive report.
2008-10-31 English
Regulatory Filings 2008
Regulatory Filings
2008-09-18 Danish
Director's Dealing 2008
Director's Dealing Classification · 100% confidence The document explicitly details 'TRADING BY MANAGEMENT IN NOVOZYMES A/S B SHARES' and lists transactions made by an executive ('Peder Holk Nielsen | EVP, Enzymes Business') on a specific date. This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS.
2008-09-18 English
Interim / Quarterly Report 2008
Interim / Quarterly Report
2008-08-14 Danish
Interim / Quarterly Report 2008
Interim / Quarterly Report
2008-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.